(TRI) Thomson Reuters Common - Overview
Stock: Legal Research, Tax Software, News Agency, Compliance Tools, Print Publications
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.43% |
| Yield on Cost 5y | 3.06% |
| Yield CAGR 5y | 10.09% |
| Payout Consistency | 94.0% |
| Payout Ratio | 83.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 74.7% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.16 |
| Alpha | -56.81 |
| Character TTM | |
|---|---|
| Beta | 0.477 |
| Beta Downside | 0.459 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.56% |
| CAGR/Max DD | -0.15 |
Description: TRI Thomson Reuters Common December 17, 2025
Thomson Reuters Corporation (NASDAQ: TRI) is a diversified content-and-technology firm operating globally across five segments: Legal Professionals, Corporates, Tax & Accounting Professionals, Reuters News, and Global Print. The business combines proprietary data, workflow software, and increasingly generative-AI tools to serve law firms, corporations, tax-and-audit practitioners, media outlets, and financial institutions.
In FY 2023 the company generated approximately $6.2 billion in revenue, with the Legal Professionals segment contributing roughly 38 % of total sales and delivering a 23 % operating margin-well above the average 15 % margin for the broader information services sector. Growth is being driven by subscription-based AI-enhanced research platforms, while macro-level spending on regulatory compliance and corporate governance remains a tailwind for the Corporates and Tax & Accounting segments. The firm’s cash conversion cycle is under 30 days, reflecting strong recurring-revenue dynamics, but earnings are sensitive to foreign-exchange fluctuations given its exposure to Europe and Asia-Pacific markets.
For a deeper, data-rich assessment of TRI’s valuation dynamics, you may find ValueRay’s analytics platform useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.80 > 1.0 |
| NWC/Revenue: -18.62% < 20% (prev -2.83%; Δ -15.79% < -1%) |
| CFO/TA 0.14 > 3% & CFO 2.46b > Net Income 1.76b |
| Net Debt (1.56b) to EBITDA (3.25b): 0.48 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (450.3m) vs 12m ago -0.04% < -2% |
| Gross Margin: 75.50% > 18% (prev 0.78%; Δ 7472 % > 0.5%) |
| Asset Turnover: 40.68% > 50% (prev 38.87%; Δ 1.81% > 0%) |
| Interest Coverage Ratio: 14.79 > 6 (EBITDA TTM 3.25b / Interest Expense TTM 158.9m) |
Altman Z'' 4.06
| A: -0.08 (Total Current Assets 2.18b - Total Current Liabilities 3.56b) / Total Assets 17.83b |
| B: 0.51 (Retained Earnings 9.10b / Total Assets 17.83b) |
| C: 0.13 (EBIT TTM 2.35b / Avg Total Assets 18.13b) |
| D: 1.93 (Book Value of Equity 11.75b / Total Liabilities 6.08b) |
| Altman-Z'' Score: 4.06 = AA |
Beneish M -2.96
| DSRI: 1.01 (Receivables 1.05b/1.01b, Revenue 7.38b/7.16b) |
| GMI: 1.03 (GM 75.50% / 77.76%) |
| AQI: 1.08 (AQ_t 0.86 / AQ_t-1 0.79) |
| SGI: 1.03 (Revenue 7.38b / 7.16b) |
| TATA: -0.04 (NI 1.76b - CFO 2.46b) / TA 17.83b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of TRI shares?
Over the past week, the price has changed by -20.39%, over one month by -32.49%, over three months by -36.35% and over the past year by -49.49%.
Is TRI a buy, sell or hold?
- StrongBuy: 1
- Buy: 3
- Hold: 11
- Sell: 0
- StrongSell: 3
What are the forecasts/targets for the TRI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 173.3 | 96.7% |
| Analysts Target Price | 173.3 | 96.7% |
| ValueRay Target Price | 70.2 | -20.3% |
TRI Fundamental Data Overview February 05, 2026
P/E Forward = 24.2718
P/S = 5.6351
P/B = 4.122
P/EG = 9.6749
Revenue TTM = 7.38b USD
EBIT TTM = 2.35b USD
EBITDA TTM = 3.25b USD
Long Term Debt = 1.34b USD (from longTermDebt, last quarter)
Short Term Debt = 837.2m USD (from shortTermDebt, last quarter)
Debt = 2.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.56b USD (from netDebt column, last quarter)
Enterprise Value = 43.12b USD (41.56b + Debt 2.17b - CCE 617.4m)
Interest Coverage Ratio = 14.79 (Ebit TTM 2.35b / Interest Expense TTM 158.9m)
EV/FCF = 23.65x (Enterprise Value 43.12b / FCF TTM 1.82b)
FCF Yield = 4.23% (FCF TTM 1.82b / Enterprise Value 43.12b)
FCF Margin = 24.72% (FCF TTM 1.82b / Revenue TTM 7.38b)
Net Margin = 23.82% (Net Income TTM 1.76b / Revenue TTM 7.38b)
Gross Margin = 75.50% ((Revenue TTM 7.38b - Cost of Revenue TTM 1.81b) / Revenue TTM)
Gross Margin QoQ = 75.87% (prev 75.46%)
Tobins Q-Ratio = 2.42 (Enterprise Value 43.12b / Total Assets 17.83b)
Interest Expense / Debt = 1.68% (Interest Expense 36.6m / Debt 2.17b)
Taxrate = 22.04% (121.0m / 549.0m)
NOPAT = 1.83b (EBIT 2.35b * (1 - 22.04%))
Current Ratio = 0.61 (Total Current Assets 2.18b / Total Current Liabilities 3.56b)
Debt / Equity = 0.19 (Debt 2.17b / totalStockholderEquity, last quarter 11.75b)
Debt / EBITDA = 0.48 (Net Debt 1.56b / EBITDA 3.25b)
Debt / FCF = 0.85 (Net Debt 1.56b / FCF TTM 1.82b)
Total Stockholder Equity = 12.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.69% (Net Income 1.76b / Total Assets 17.83b)
RoE = 14.43% (Net Income TTM 1.76b / Total Stockholder Equity 12.17b)
RoCE = 17.40% (EBIT 2.35b / Capital Employed (Equity 12.17b + L.T.Debt 1.34b))
RoIC = 12.59% (NOPAT 1.83b / Invested Capital 14.55b)
WACC = 7.35% (E(41.56b)/V(43.74b) * Re(7.67%) + D(2.17b)/V(43.74b) * Rd(1.68%) * (1-Tc(0.22)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.54%
[DCF Debug] Terminal Value 82.25% ; FCFF base≈1.91b ; Y1≈2.19b ; Y5≈3.06b
Fair Price DCF = 131.8 (EV 60.20b - Net Debt 1.56b = Equity 58.65b / Shares 444.8m; r=7.35% [WACC]; 5y FCF grow 17.36% → 2.90% )
EPS Correlation: 76.50 | EPS CAGR: 19.93% | SUE: 0.66 | # QB: 0
Revenue Correlation: 62.41 | Revenue CAGR: 1.11% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.24 | Chg30d=-0.000 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=4.44 | Chg30d=-0.012 | Revisions Net=-3 | Growth EPS=+14.1% | Growth Revenue=+7.6%